Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: A clinical overview

150Citations
Citations of this article
376Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Iron deficiency anaemia represents a major public health problem, particularly in infants, young children, pregnant women, and females with heavy menses. Oral iron supplementation is a cheap, safe, and effective means of increasing haemoglobin levels and restoring iron stores to prevent and correct iron deficiency. Many preparations are available, varying widely in dosage, formulation (quick or prolonged release), and chemical state (ferrous or ferric form). The debate over the advantages of ferrous versus ferric formulations is ongoing. In this literature review, the tolerability and efficacy of ferrous versus ferric iron formulations are evaluated. We focused on studies comparing ferrous sulphate preparations with ferric iron polymaltose complex preparations, the two predominant forms of iron used. Current data show that slow-release ferrous sulphate preparations remain the established and standard treatment of iron deficiency, irrespective of the indication, given their good bioavailability, efficacy, and acceptable tolerability demonstrated in several large clinical studies. Copyright © 2012 Palacios Santiago.

Cite

CITATION STYLE

APA

Santiago, P. (2012). Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: A clinical overview. The Scientific World Journal. https://doi.org/10.1100/2012/846824

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free